Skip to main content
Tech executives and AI researchers discuss DNA security legislation as artificial intelligence surpasses PhDs in virology ana

Editorial illustration for AI outperforms PhDs in virology, leading tech CEOs to push DNA security bills

AI outperforms PhDs in virology, leading tech CEOs to...

AI outperforms PhDs in virology, leading tech CEOs to push DNA security bills

2 min read

AI can now coach amateur virologists, and a handful of tech CEOs are urging Congress to tighten DNA‑security rules. While the science community has known for more than two decades that synthetic DNA can be used to rebuild viruses, a new AI benchmark shows the technology outperforming PhD‑level virologists on procedural questions. Here’s the thing: that capability narrows the knowledge gap that once kept malicious actors at bay.

In response, an open letter signed by OpenAI’s Sam Altman, Anthropic’s Dario Amodei, DeepMind’s Demis Hassabis, Microsoft AI’s Mustafa Suleyman and Nobel laureates David Baker and Martin Hellman calls for a legal requirement that all synthetic‑DNA providers screen orders. Many firms already do it voluntarily, but the signatories want uniform rules, including record‑keeping for traceability. They argue screening is one of the most effective, least restrictive biosecurity measures available.

The letter stresses that this rare consensus among typically opposing stakeholders should prompt Congress to act this session.

Scientists have known for more than 20 years that viruses can be reconstructed from synthetic DNA. AI systems now outperform PhD-level virologists on questions about lab procedures, raising the risk of misuse. Many providers already screen orders voluntarily, but the signatories want uniform rules for all manufacturers, including recordkeeping requirements for traceability.

AI systems are improving rapidly, and alongside incredible benefits to science and medicine, there is a real possibility that the knowledge barriers which have historically prevented bad actors from obtaining biological weapons will meaningfully erode. Open letter The signatories stress that screening is one of the most effective and least restrictive biosecurity measures available.

Why this matters

AI now outperforms PhD‑level virologists on lab‑procedure questions, a fact that raises the spectre of misuse. Can we trust a system that can coach amateur virologists while scientists have warned for two decades that synthetic DNA can recreate viruses? The open letter signed by Sam Altman, Dario Amodei, Demis Hassabis, Mustafa Suleyman and Nobel laureates David Baker and Martin Hellman asks Congress to make synthetic‑DNA screening a legal requirement.

Many suppliers already screen orders voluntarily, yet the signatories argue for uniform rules. We see a clear tension: powerful tools for discovery on one side, and a potential shortcut for biothreat actors on the other. Unclear whether mandatory screening will curb the risk or simply shift it elsewhere.

For developers and founders, the message is cautious: advancing AI capabilities must be matched with policy that keeps pace, and researchers should monitor how legal frameworks evolve. Our community should stay alert, question assumptions, and demand transparency as these technologies intersect with biosecurity.

Further Reading